Sign in
4

Changes in Ownership

AGIOS PHARMACEUTICALS, INC. Filed Acc 0001209191-17-051430

Chief Executive Officer sold 6,000 shares at $62.20 ($373,200)

  • Chief Executive Officer acquired 6,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-09-01 Option exercise +6,000 $0.30 $1,815 6,000 D: show line 1 in the form
Schenkein David P Chief Executive Officer 2017-09-01 Sale −6,000 $62.20 $373,200 0 D: show line 2 in the form
Open-market sales · 6,000 sh · avg $62.20 · $373,200

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Schenkein David P Chief Executive Officer 2017-09-01 Option exercise · Stock option (right to buy) −6,000 153,656 D: show line 3 in the form
Loading xslF345X03/doc4.xml…